• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials.停止基层医疗中长期用药的影响:药物减量试验的系统评价。
Br J Gen Pract. 2018 Oct;68(675):e663-e672. doi: 10.3399/bjgp18X699041.
2
[MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].[老年疗养院居民的药物停用]
Harefuah. 2016 Mar;155(3):145-9, 197.
3
Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.老年人及护理人员对减药的看法和态度:一项定性焦点小组研究
Br J Gen Pract. 2016 Aug;66(649):e552-60. doi: 10.3399/bjgp16X685669. Epub 2016 Jun 6.
4
Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.养老院老年居民药物减量干预的健康结局:系统评价和荟萃分析。
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11. doi: 10.1016/j.jamda.2018.10.026. Epub 2018 Dec 21.
5
The value of deprescribing in older adults with dementia: a narrative review.老年痴呆症患者药物减量的价值:叙事性综述。
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
6
Deprescribing as a Way to Reduce Inappropriate Use of Drugs for Overactive Bladder in Primary Care (DROP): Protocol for a Cluster Randomized Controlled Trial With an Embedded Explanatory Sequential Mixed Methods Study.中文译文:从初级保健中减少药物过度使用治疗膀胱过度活动症的药物停用方案(DROP):一项群组随机对照试验的方案,该试验嵌入了一个解释性序贯混合方法研究。
JMIR Res Protoc. 2024 Jul 23;13:e56277. doi: 10.2196/56277.
7
Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.使用常规收集的医疗保健数据对养老院居民进行药物减量研究:概念框架。
BMC Geriatr. 2023 Aug 4;23(1):469. doi: 10.1186/s12877-023-04194-5.
8
Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.药剂师主导的减药干预对养老院居民的影响:一项随机对照试验。
Int J Clin Pharm. 2020 Aug;42(4):1153-1167. doi: 10.1007/s11096-020-01073-6. Epub 2020 Jun 3.
9
How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?医生对老年患者减药治疗的信心如何,以及哪些障碍阻碍了减药治疗?
J Clin Pharm Ther. 2018 Aug;43(4):550-555. doi: 10.1111/jcpt.12688. Epub 2018 Apr 22.
10
Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials.在初级保健环境中管理慢性病药物的停药:随机对照试验的系统评价。
J Am Med Dir Assoc. 2018 Nov;19(11):923-935.e2. doi: 10.1016/j.jamda.2018.06.021. Epub 2018 Aug 11.

引用本文的文献

1
Development of a complex multidisciplinary medication review and deprescribing intervention in primary care for older people living with frailty and polypharmacy.为患有衰弱和多重用药的老年人开展一项复杂的多学科药物评估与减药干预的初级保健项目。
PLoS One. 2025 Apr 22;20(4):e0319615. doi: 10.1371/journal.pone.0319615. eCollection 2025.
2
Medicine Optimisation and Deprescribing Intervention Outcomes for Older People with Dementia or Mild Cognitive Impairment: A Systematic Review.痴呆症或轻度认知障碍老年人的药物优化与减药干预结果:一项系统评价
Drugs Aging. 2025 Apr;42(4):275-294. doi: 10.1007/s40266-025-01189-2. Epub 2025 Mar 11.
3
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.减药对肌肉减少症参数的证据及影响:一项系统综述
BMC Geriatr. 2025 Mar 7;25(1):158. doi: 10.1186/s12877-025-05819-7.
4
The patient's perspectives of safe and routine proactive deprescribing in primary care for older people living with polypharmacy: a qualitative study.患者对老年人多病共存情况下常规安全主动精简用药的看法:一项定性研究。
BMC Geriatr. 2024 Oct 16;24(1):844. doi: 10.1186/s12877-024-05435-x.
5
An Internationally Derived Process of Healthcare Professionals' Proactive Deprescribing Steps and Constituent Activities.医疗保健专业人员主动减药步骤及构成活动的国际衍生流程。
Pharmacy (Basel). 2024 Sep 9;12(5):138. doi: 10.3390/pharmacy12050138.
6
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.老年人减药的电子咨询:临床医生对实施障碍和促进因素的看法
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
7
Deprescribing interventions in older adults: An overview of systematic reviews.老年患者减药干预措施的系统评价概述。
PLoS One. 2024 Jun 17;19(6):e0305215. doi: 10.1371/journal.pone.0305215. eCollection 2024.
8
Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media.患者报告的降压药物更换原因:使用社交媒体的定量研究。
Drug Saf. 2024 Jan;47(1):81-91. doi: 10.1007/s40264-023-01366-5. Epub 2023 Nov 23.
9
Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation.对不同意药物减量建议的老年人来说很重要的因素。
JAMA Netw Open. 2023 Oct 2;6(10):e2337281. doi: 10.1001/jamanetworkopen.2023.37281.
10
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.多学科药物审查和减少老年人用药干预措施在初级保健中为何能良好运行?一项实际审查和综合研究。
BMC Geriatr. 2023 Sep 25;23(1):591. doi: 10.1186/s12877-023-04256-8.

本文引用的文献

1
Effectiveness of medication withdrawal in older fallers: results from the Improving Medication Prescribing to reduce Risk Of FALLs (IMPROveFALL) trial.老年人跌倒者停药的效果:来自改善药物处方以降低跌倒风险(IMPROveFALL)试验的结果。
Age Ageing. 2017 Jan 10;46(1):142-146. doi: 10.1093/ageing/afw161.
2
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.老年人减药对死亡率和健康的可行性及效果:一项系统评价与荟萃分析
Br J Clin Pharmacol. 2016 Sep;82(3):583-623. doi: 10.1111/bcp.12975. Epub 2016 Jun 13.
3
A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.一项运用网络分析对“减药”这一新兴定义的系统评价:对未来研究和临床实践的启示
Br J Clin Pharmacol. 2015 Dec;80(6):1254-68. doi: 10.1111/bcp.12732.
4
Deprescribing in Frail Older People: A Randomised Controlled Trial.老年体弱患者的减药治疗:一项随机对照试验。
PLoS One. 2016 Mar 4;11(3):e0149984. doi: 10.1371/journal.pone.0149984. eCollection 2016.
5
Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.停用潜在不适当的预防性心血管药物:患者和全科医生面临的障碍与促进因素
Ann Pharmacother. 2016 Jun;50(6):446-54. doi: 10.1177/1060028016637181. Epub 2016 Mar 3.
6
Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.基于正念的认知疗法治疗复发性抑郁症后停用抗抑郁药物:随机对照非劣效性试验。
Br J Psychiatry. 2016 Apr;208(4):366-73. doi: 10.1192/bjp.bp.115.168971. Epub 2016 Feb 18.
7
Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden.停用抗高血压药物对轻度认知障碍老年人直立性低血压的影响:莱顿但丁研究
Age Ageing. 2016 Mar;45(2):249-55. doi: 10.1093/ageing/afv199. Epub 2016 Jan 11.
8
Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study.停用坦索罗辛对服用坦索罗辛和度他雄胺的韩国良性前列腺增生男性患者的影响:一项开放标签、前瞻性、随机试验研究。
Low Urin Tract Symptoms. 2012 Jan;4(1):35-40. doi: 10.1111/j.1757-5672.2011.00109.x. Epub 2011 Nov 8.
9
Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study.80岁及以上患者多重用药的发生率及其对临床结局的影响:一项五年随访研究
PLoS One. 2015 Nov 10;10(11):e0142123. doi: 10.1371/journal.pone.0142123. eCollection 2015.
10
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.1999 - 2012年美国成年人处方药使用趋势
JAMA. 2015 Nov 3;314(17):1818-31. doi: 10.1001/jama.2015.13766.

停止基层医疗中长期用药的影响:药物减量试验的系统评价。

Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials.

机构信息

Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.

Primary Care Clinical Unit, Faculty of Medicine, the University of Queensland, Brisbane, Australia.

出版信息

Br J Gen Pract. 2018 Oct;68(675):e663-e672. doi: 10.3399/bjgp18X699041.

DOI:10.3399/bjgp18X699041
PMID:30249607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6145971/
Abstract

BACKGROUND

Polypharmacy is becoming more prevalent and evaluation of appropriateness of medication use is increasingly important. The primary care physician often conducts the deprescribing process; however, there are several barriers to implementing this.

AIM

To examine the feasibility and safety of discontinuation of medication, with a focus on studies that have been conducted in the community, that is, primary care (or general practice) and nursing homes.

DESIGN AND SETTING

This systematic review included randomised controlled trials published in 2005-2017, which studied withdrawal of long-term drugs prescribed in primary care settings and compared continuing medication with discontinuing.

METHOD

PubMed and EMBASE searches were conducted and the extracted data included the number of patients who successfully stopped medication and the number of patients who experienced relapse of symptoms or restarted medication.

RESULTS

A total of 27 studies reported in 26 papers were included in this review. The number of participants in the studies varied from 20 to 2471 and the mean age of participants ranged from 50.3 years to 89.2 years. The proportion of patients who successfully stopped their medication varied from 20% to 100%, and the range of reported relapse varied from 1.9% to 80%.

CONCLUSION

Only a few studies have examined the success rate and safety of discontinuing medication in primary care, and these studies are very heterogeneous. Most studies show that deprescribing and cessation of long-term use seem safe; however, there is a risk of relapse of symptoms. More research is needed to advise physicians in making evidence-based decisions about deprescribing in primary care settings.

摘要

背景

多种药物治疗变得越来越普遍,评估药物使用的适当性变得越来越重要。初级保健医生通常会进行减药过程,但这存在几个障碍。

目的

检查停止用药的可行性和安全性,重点关注在社区(即初级保健(或全科医学)和疗养院)进行的研究。

设计和设置

本系统评价纳入了 2005 年至 2017 年发表的随机对照试验,研究了在初级保健环境中停止长期处方药物的情况,并将继续用药与停药进行了比较。

方法

进行了 PubMed 和 EMBASE 检索,提取的数据包括成功停止用药的患者人数和症状复发或重新开始用药的患者人数。

结果

本综述共纳入 26 篇论文中的 27 项研究。研究参与者人数从 20 人到 2471 人不等,参与者的平均年龄从 50.3 岁到 89.2 岁不等。成功停止用药的患者比例从 20%到 100%不等,报告的复发率从 1.9%到 80%不等。

结论

只有少数研究检查了初级保健中停止用药的成功率和安全性,这些研究非常异质。大多数研究表明,减药和停止长期使用似乎是安全的;然而,存在症状复发的风险。需要进一步研究,为医生在初级保健环境中做出基于证据的减药决策提供建议。